01March

Change in Novo Nordisk Executive Management ... Read more

28February

Novo Nordisk files for regulatory approval of once-weekly semaglutide for the tr ... Read more

24February

Notice for the Annual General Meeting of Novo Nordisk A/S ... Read more

09February

Novo Nordisk files annual report with the SEC ... Read more

20March

Novo Nordisk A/S - Share repurchase programme ... Read more

13March

Novo Nordisk A/S - Share repurchase programme ... Read more

06March

Novo Nordisk A/S - Share repurchase programme ... Read more

01March

Change in Novo Nordisk Executive Management ... Read more

23March

Annual General Meeting 2017,

24March

Ex-dividend,

27March

Record date,

28March

Payment B shares,

 

 

 

Investors

 
Share information


Take an advanced view of the Novo Nordisk share

 
FY 2016 financial results 

 

Full-year 2016 conference call and roadshow presentation

 
Annual Report 2016


Download the Novo Nordisk Annual Report 2016



Novo Nordisk at a glance


Private shareholders


See relevant content for private investors



IR material


Download relevant Investor Relations material



Contacts



Subscriptions


Sign up to receive company announcements.



DEVOTE conference call

 

DEVOTE conference call